Test Price
1,700 AED✅ Home Collection Available
Limb‑Girdle Muscular Dystrophy (LGMD) Genetic Testing in UAE | 1,700 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance with a DHA‑licensed Consultant Medical Geneticist for result interpretation.
- Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.
Test Overview & Methodology
Limb‑girdle muscular dystrophy (LGMD) genetic testing utilises next‑generation sequencing (NGS) to analyse multiple genes associated with progressive muscle weakness, confirming a molecular diagnosis and guiding clinical management, prognosis, and family risk assessment. Our comprehensive NGS panel covers all coding exons and splice sites of over 30 LGMD‑associated genes, detecting single‑nucleotide variants, small insertions or deletions, and copy number variations.
| Feature | Our LGMD NGS Panel | Closest Alternative |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; covers all exons and splice sites across >30 LGMD genes | Single‑gene Sanger sequencing, limited to 1‑2 genes, lower sensitivity |
| Method | Next‑Generation Sequencing (NGS) with deletion/duplication analysis | Sanger sequencing or targeted mutation screening |
| Speed | Results in 21 days | Typically 30–45 days |
Physician Insight & Safety Protocols
From Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403):
“Genetic confirmation of LGMD through a comprehensive NGS panel empowers patients and families with a precise diagnosis, enabling tailored surveillance, reproductive planning, and access to emerging therapies. I encourage patients to view genetic testing as a pivotal step in a collaborative care journey with their neuromuscular specialist.”
Important Medication Advisory
⚠️ Do Not Discontinue Prescribed Medication Without Consulting Your Doctor
If you are currently receiving treatment for muscle weakness or any related condition, continue all medications as directed by your physician. The genetic testing process does not require any change to your existing therapy unless specifically instructed by the managing specialist.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
This test is not intended for individuals with a confirmed alternative genetic diagnosis established through a validated method. A pre‑test clinical evaluation and detailed family history are mandatory; incomplete documentation may delay processing.
Emergency Red Flags
If you experience sudden, marked worsening of muscle weakness, breathing difficulties, chest pain, or loss of ambulation, seek emergency medical care immediately. These symptoms require urgent assessment independent of test scheduling.
Patient FAQ & Clinical Guidance
1. What is included in the LGMD genetic panel?
Our comprehensive LGMD panel analyses all coding regions and splice sites of over 30 associated genes using next‑generation sequencing. It detects single‑nucleotide variants, small insertions or deletions, and copy number variations, delivering a molecular diagnosis in most typical forms of the disease.
2. How should I prepare before giving the blood sample?
No fasting or special preparation is required. However, a complete family history and relevant clinical notes must be submitted prior to collection. Our home‑collection team will review the required forms with you before the blood draw.
3. How long do results take and who will explain them?
Results are delivered within 21 calendar days. A board‑certified consultant medical geneticist provides a telephonic post‑test consultation to ensure you fully understand the report and its implications for care, surveillance, and family planning.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are encrypted, access‑controlled, and processed under strict confidentiality protocols. Clinical testing safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Limb‑Girdle Muscular Dystrophy (LGMD) Genetic Testing (NGS Panel) |
| Price (AED) | 1,700 AED |
| Turnaround Time | 21 Days |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) with deletion/duplication analysis |
| ICD‑10‑CM Code | G71.0 |
| LOINC Code | 94230-1 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians